Enter multiple symbols separated by commas

Stocks Boston Scientific Corp


  • In an Aug. 31 filing in federal court in Toledo, Ohio, the defendant asked the court to compel MedStar to turn over more information about the liens, so it can investigate whether the funder schemed to "artificially inflate damages claims." According to DePuy, MedStar submitted claims for nearly $1.5 million for 11 surgeries that should have cost no more than...

  • Trader: Where to find value in the selloff Wednesday, 2 Sep 2015 | 7:11 AM ET
    TJ Maxx TK Maxx stores

    Aureus Asset Management CEO Karen Firestone says there's value in U.S.-centric consumer and health-care stocks.

  • Aug 19- Medical device maker Boston Scientific Inc said its stent to prevent the blocking of arteries in the legs was approved in the United States, four years after the device was recalled outside the country due to partial or no deployments. Boston Scientific also develops another medical device called Eluvia Stent that uses Innova's technology and is...

  • NEW YORK, Aug 18- In July 2013, California urogynecologist Andrew Cassidenti received an email from an entrepreneur named Otto Fisher, who had a proposition. In a phone call, Fisher said he needed doctors to operate at outpatient centers in California and Las Vegas. Fisher said he could guarantee Cassidenti $2,500 for every surgery the doctor performed, "whether...

  • July 23- Boston Scientific Corp cut its full-year profit forecast for the second time in the face of rising litigation costs linked to problems with its implantable device used to treat feminine stress urinary incontinence. A Delaware jury last month ordered Boston Scientific to pay $100 million to a woman injured by the mesh, the largest-ever verdict...

  • Boston Scientific profit soars Thursday, 23 Jul 2015 | 7:10 AM ET

    July 23- Medical device maker Boston Scientific Corp, dogged by litigation expenses last year, reported a jump in quarterly profit. Net income attributable to the company rose to $102 million, or 8 cents per share, in the second quarter ended June 30, from $4 million, or break even on a per share basis, a year earlier. Revenue fell 1.6 pct to $1.84 billion.

  • Pfizer Inc, the largest U.S. drugmaker, for example reported more than $234.2 million in research payments and another $53.3 million in general payments. John Diliberti, a pediatric geneticist from Illinois, collected nearly $447,000 from Pfizer in consulting fees last year, the biggest single payment to an individual doctor by the drugmaker.

  • Lightning Round: Time to take profits on this Friday, 29 May 2015 | 7:00 PM ET
    Mad Money Lightning Round

    It's Lightning Round time! Jim Cramer gives his take at lightning speed for a few caller favorite stocks.

  • May 28- A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh, a device that is the subject of more than 25,000 lawsuits against the company. The 51- year old Newark, Delaware- resident was implanted with Boston Scientific's Pinnacle and Advantage Fit mesh products in 2009, to treat...

  • The 10 stocks likely to drop this summer: Goldman Friday, 15 May 2015 | 6:00 AM ET
    Traders work on the floor of the New York Stock Exchange (NYSE) on Friday.

    Goldman Sachs' options team recommended this week that clients bet against 10 stocks that look most vulnerable to summer swoons.

  • April 28- Boston Scientific Corp on Tuesday said it reached its first settlement agreement to resolve a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence. The new agreement includes a case in the district court of Dallas County, Texas, for which there is a judgment of about $35 million that is subject to...

  • April 28- Medical device maker Boston Scientific Corp cut its full-year revenue and profit forecasts as it continues to bear the brunt of charges from a number of lawsuits. Boston Scientific said in February it would pay Johnson& Johnson $600 million to settle a long-running lawsuit over Boston Scientific's acquisition of rival Guidant in 2005..

  • Boston Scientific posts loss on litigation costs Tuesday, 28 Apr 2015 | 7:22 AM ET

    April 28- Medical device maker Boston Scientific Corp reported a quarterly net loss due to one-time charges, including litigation costs of $193 million. The company reported a net loss of $1 million for the first quarter ended March 31, compared with a profit of $133 million a year earlier. Excluding charges, the company earned 21 cents per share.

  • NEW YORK, April 24- Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector. Companies reporting first-quarter earnings next week include Bristol-Meyers Squibb Co,...

  • Cramer: Problem feeding all investing decisions now Tuesday, 31 Mar 2015 | 6:11 PM ET
    A trader works on the floor of the New York Stock Exchange.

    Jim Cramer sees there is one problem that is effecting every investment decision made right now. Will it continue into the second quarter?

  • Box nabs US government IT executive Thursday, 19 Mar 2015 | 1:08 PM ET
    Aaron Levie, CEO of Box, speaks during the BoxWorks 'How Tomorrow Works' event in San Francisco, California.

    The former CIO of the General Services Administration will lead Box's efforts to lure government agencies to move to its cloud platform.

  • Why biotech investors may be hurting innovation Friday, 13 Mar 2015 | 3:27 PM ET

    Over the past five years, investor money is increasingly moving toward consumer software and later-stage life science ventures, a trend that could help develop new treatments.

  • Early movers: BRK.B, AAPL, LL, CAH, BSX & more Monday, 2 Mar 2015 | 7:50 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Early movers: HLT, HOT, ACT, FOSL, CAT & more Wednesday, 18 Feb 2015 | 7:50 AM ET
    Traders on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Cramer's hottest stocks on the market right now Tuesday, 17 Feb 2015 | 6:10 PM ET
    Models pose during the Kate Spade presentation during Fashion Week in New York.

    In honor of fashion week Jim Cramer reviews the trending stocks of the moment, including this popular security group.